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Bacterial fibronectin-binding proteins (FnBPs) contain a
large intrinsically disordered region (IDR) that mediates adhe-
sion of bacteria to host tissues, and invasion of host cells,
throughbinding to fibronectin (Fn). These FnBP IDRs consist of
Fn-binding repeats (FnBRs) that formahighly extended tandem
-zipper interactiononbinding to theN-terminal domainof Fn.
Several FnBR residues are highly conserved across bacterial spe-
cies, and here we investigate their contribution to the interac-
tion. Mutation of these residues to alanine in SfbI-5 (a disor-
dered FnBR from the human pathogen Streptococcus pyogenes)
reduced binding, but for each residue the change in free energy
of binding was <2 kcal/mol. The structure of an SfbI-5 peptide
in complex with the second and third F1 modules from Fn con-
firms that the conserved FnBR residues play equivalent func-
tional roles across bacterial species. Thus, in SfbI-5, the binding
energy for the tandem -zipper interaction with Fn is distrib-
uted across the interface rather than concentrated in a small
number of “hot spot” residues that are frequently observed in
the interactions of folded proteins. We propose that this might
be a common feature of the interactions of IDRs and is likely to
pose a challenge for the development of small molecule inhibi-
tors of FnBP-mediated adhesion to and invasion of host cells.
In the last 20 years there has been increasing recognition of
the functional importance of regions of protein sequence that
lack a stable tertiary fold under physiological conditions (1, 2).
Previously, the “structure-function paradigm” asserted that a
protein must be stably folded to be functional. However, it has
since been shown that intrinsically disordered regions (IDRs)4
are involved in key molecular recognition events in both phys-
iological (3) and pathological processes (4) and that IDRs often
become structured on binding (5).
Our previous work has shown that cell wall-attached pro-
teins expressed by some staphylococci and streptococci species
and also the Lyme disease-causing spirochete, Borrelia burg-
dorferi, contain IDRs that bind the protein fibronectin (Fn)
through a highly unusual mechanism of protein-protein recog-
nition that we call a tandem -zipper (6–11). This work inves-
tigates the thermodynamics of this interaction by studying the
binding of Fn to SfbI, an Fn-binding protein (FnBP) from Strep-
tococcus pyogenes.
Fn is a chordate glycoprotein (12). It is found as a disulfide-
linked dimer in human plasma and in an insoluble fibrillar form
as a component of extracellular matrices. Fn plays an essential
role in development (13, 14) and in other processes requiring
cell migration, such as wound healing and tissue remodeling
(15). Fn is a modular protein, and the N-terminal domain
(NTD) contains a string of five Fn type I (F1) modules (1–5F1)
whose sequences are highly conserved across vertebrates (16).
IDRs within bacterial FnBPs interact with these F1 modules.
S. pyogenes is an important human pathogen that causes
common infections of the throat and skin such as pharyngitis
and impetigo, and it can also cause more severe invasive infec-
tions such as streptococcal toxic shock syndrome and necrotiz-
ing fasciitis (reviewed in Ref. 17). SfbI mediates bacterial inva-
sion of epithelial cells and endothelial cells (18–20) by binding
to Fn, which acts as a bridge between SfbI and host cell integ-
rins. Internalization might allow S. pyogenes to avoid anti-mi-
crobial drugs and host-defense mechanisms (reviewed in Refs.
21, 22) and thus is a potential target for new therapeutics.
Biophysical studies have shown that an FnBP from Staphylo-
coccus aureus contains a series of intrinsically disordered Fn-
binding repeats (FnBRs) that undergo a disorder-to-order tran-
sition on binding either 2–4F1 or 2–5F1 from theNTD of Fn (10,
24, 25). In this tandem -zipper interaction, the FnBR extends
the triple-stranded anti-parallel -sheet of sequential F1 mod-
ules by forming an additional strand anti-parallel to the C-ter-
* This work was supported by a British Heart Foundation Senior Basic Science
Fellowship (to J. R. P.), an Overseas Research Students Awards Scheme
Scholarship, scholarships from the Universities of Sydney and York (to
N. N.), and by Biotechnology and Biological Sciences Research Council
Grant D010608/1.
 This article was selected as a Paper of the Week.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Tables 1–3.
The atomic coordinates and structure factors (code 3zrz) have been deposited in
the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,
Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
1 Present address: The John Curtin School of Medical Research, Australian
National University, Canberra, Australian Capital Territory 0200, Australia.
2 Present address: Dept. of Chemical and Biological Sciences, School of
Applied Sciences, University of Huddersfield, Queensgate, Huddersfield,
HD1 3DH, United Kingdom.
3 To whom correspondence should be addressed. Tel.: 44-1904-328679;
E-mail: jennifer.potts@york.ac.uk.
4 The abbreviations used are: IDR, intrinsically disordered region; FnBP,
fibronectin-binding protein; Fn, fibronectin; FnBR, Fn-binding repeat; NTD,
N-terminal domain; F1, Fn type 1; ITC, isothermal titration calorimetry; PDB,
Protein Data Bank; HMM, Hidden Markov Model; SSP, secondary structure
propensity; SPR, surface plasmon resonance; ASA, accessible surface area.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 44, pp. 38311–38320, November 4, 2011
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
NOVEMBER 4, 2011 • VOLUME 286 • NUMBER 44 JOURNAL OF BIOLOGICAL CHEMISTRY 38311
 at A
ustralian N
ational U
niversity, on M
ay 16, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
_profile.html 
http://www.jbc.org/content/suppl/2011/10/27/M111.276592.DCAuthor
http://www.jbc.org/content/suppl/2011/08/12/M111.276592.DC1.html 
Supplemental Material can be found at:
minal strand (strand E) of each F1 module (7, 25). SfbI from S.
pyogenes contains five FnBRs that each bind the NTD of Fn (7,
8, 22). SfbI-5, themost C-terminal FnBR, also has a 1F1-binding
motif and can therefore bind all five F1 modules (1–5F1). To
date, 1F1-bindingmotifs have only been identified in the C-ter-
minal streptococcal FnBRs (7, 22).
The thermodynamics of protein-protein interactions involv-
ing two folded proteins have been well studied. Mutational
analyses show that the free energy of binding is often concen-
trated within a few hot spot residues (26) (change in Gibbs free
energy of binding, G0, on mutation of 2 kcal/mol) rather
than being distributed evenly across the interface (27). The abil-
ity to identify hot spot residues is particularly important for the
discovery of drugs that target protein-protein interactions (28),
and there are now a number of web servers that will perform
such predictions (29–31). Much less is known about the ther-
modynamics of the interactions of IDRs.
In this study we demonstrate that SfbI-5 is an IDR. We use a
Hidden Markov Model (HMM) to identify the most conserved
FnBR residues across bacterial species. We show that for the
NTD/SfbI-5 tandem -zipper interaction, residues that are
highly conserved across FnBRs, and that form very similar
intermolecular interactions in NTDFnBR complexes across
bacterial species, are not hot spot residues. Therefore, unlike
many interfaces formed between folded proteins, for SfbI-5 the
binding energy is distributed across the interface. We suggest
this might be a feature of the rather extended interactions that
many IDRs form relative to folded proteins (32). The distrib-
uted energy of binding will pose a challenge to the development
of small molecules that inhibit FnBP-mediated adhesion to and
invasion of host cells.
EXPERIMENTAL PROCEDURES
Proteins, Proteolytic Fragments, Synthetic Peptides, Protein
Expression, and Purification—The synthetic peptide PyTT5,
corresponding to residues 560–577 of SfbI (UniProt accession
Q01924), was purchased from Alta Bioscience (Birmingham,
UK). The N and C termini were capped by acetylation and ami-
dation, respectively. Human plasma Fn was purchased from
Sigma (product no. F0895). The N-terminal domain from
humanplasma Fn, containing 1–5F1, was purchased as a 30-kDa
proteolytic fragment from Sigma (product no. F9911) and is
referred to as pNTD herein. The N and C termini were deter-
mined by mass spectrometry (MS) using an apex ultra FTMS
(Bruker Daltonics).
2F13F1 (residues 62–151 ofmature human Fn)was expressed
inPichia pastoris and purified using procedures similar to those
described previously (7, 33). SfbI-5 (corresponding to residues
541–591 of SfbI) was expressed as a recombinant glutathione
S-transferase (GST) fusion using the pGEX-5X-SfbI-5 con-
struct described previously (7). Escherichia coli BL21 Gold
competent cells (Stratagene)were transformedwith pGEX-5X-
SfbI-5 using a rapid protocol (34). A culture of a single trans-
formed colony inoculated into LB-Amp broth (1% (w/v) tryp-
tone, 0.5% (w/v) yeast extract, 1% NaCl (w/v), 100 g/ml
ampicillin) was grown for 18 h at 37 °C and then diluted into
LB-Ampbroth and incubatedwith shaking at either 30 or 37 °C.
Cultures were induced to overexpress the GST fusion with iso-
propyl -D-thiogalactopyranoside when the OD at 600 nm was
between 0.6 and 1.2 and were then grown for a further 17 h
(30 °C) or 3 h (37 °C). TheGST fusion proteinwas purified from
cleared cell lysates using glutathione-Sepharose (GE
Healthcare).
For isothermal titration calorimetry (ITC) and NMR exper-
iments, SfbI-5 was cleaved fromGSTwith Factor Xa (NewEng-
land Biolabs), purified by reversed-phase high performance liq-
uid chromatography (8), and lyophilized. The mass of the
purified product was confirmed by MS. 15N,13C-labeled SfbI-5
was produced using similar methods but using isotope-labeled
minimal media.
Site-directed Mutagenesis—All SfbI-5 mutants were created
through site-directed mutagenesis of pGEX-5X-SfbI-5 using
the QuikChange II mutagenesis kit (Stratagene) and the prim-
ers in supplemental Table 1. In-house DNA sequencing con-
firmed the presence of mutations. SfbI-5 mutants were
expressed, purified, and lyophilized as for wild-type SfbI-5, and
their masses were confirmed by MS.
ITC—Thebinding of pNTD to SfbI-5 and SfbI-5mutantswas
measured in PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4,
1.8 mM KH2PO4) at 37 °C using a VP-ITC microcalorimeter
(MicroCal) and a procedure very similar to that reported pre-
viously (8). For each SfbI-5 peptide, an ITC experiment con-
sisted of a binding titration and a control titration; the SfbI-5
peptide titrated into PBS with or without pNTD, respectively.
The experiments were performed with pNTD (1.4–4 M) in
the cell and the peptide (20–50 M) in the syringe. The exper-
iments with the following SfbI-5 peptides were performed
twice: SfbI-5, F554A, K556A, K556E, D574A, and T575A; and
those with T558A were performed three times. Data were ana-
lyzed and fitted to a single site binding model using nonlinear
regression analysis in Origin 7.0 software (MicroCal).
The concentration of pNTD was determined by absorbance
at 280 nm using a theoretical extinction coefficient, based on
the amino acid sequence, of 63,130 M1 cm1. The concentra-
tion of the SfbI-5 peptide was initially estimated from the
weight of lyophilized material and then determined for one
syringe sample for the following SfbI-5 peptides by quantitative
amino acid analysis (Alta Bioscience, Birmingham): SfbI-5,
F554A, K556A, K556E, T558A, and D574A. Use of these pep-
tide concentrations resulted inmolar ratio of binding (n) values
within 12% of 1.0. Thus, for all other titrations, the peptide
concentrations were corrected during analysis to give an n
value of 1. Heats of dilutionwere either the injectionof the appro-
priate peptide into buffer or the average peak area of the last 5 or
10 injections from the binding titration. For those SfbI-5
mutantswhose ITCexperimentswere repeated, themean value
of each parameter was used for subsequent analysis.
NMR Spectroscopy—A standard suite of triple resonance
experiments was performed for sequential assignment of
15N,13C-labeled SfbI-5 (1 mM, pH 5.5, 10% (v/v) D2O, 0.02%
(w/v) NaN3). All were acquired using standard Bruker pulse
sequences on a Bruker AVII 700 MHz spectrometer equipped
with a triple resonance probe and z axis gradients at 25 °C. Data
were processed using NMRPipe (35) and analyzed using CCPN
Analysis (36).
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Secondary structure propensity (SSP) was calculated from
the assigned chemical shifts of the SfbI-5 1HN, 15NH, 13C, 13C,
and 13C nuclei (supplemental Table 2) using the SSP PerlScript
kindly made available for download by Marsh et al. (37). The
input used for the script was the experimentally determined
SfbI-5 chemical shifts and the statistically derived random coil
dataset from Wang and Jardetzky (38). Appropriate sequence
correction values for the randomcoil dataset (38)were added to
the corresponding observed SfbI-5 chemical shifts before SSP
score calculation.
X-ray Crystallography—Crystals of 2F13F1PyTT5 (0.3 and
3.5mM, pH7.7)were grownusing sitting drop vapor diffusion
from a 1:1 dilution with the well solution. The well solution was
either 20 mMMgCl2, 0.1 M HEPES, pH 7.5, 22% w/v polyacrylic
acid, or 0.1 M Tris, pH 7.0, 1.5 M (NH4)2SO4 for the lower and
higher resolution data, respectively. Crystals were flash-cooled
in liquid nitrogen using 20 or 30% (v/v) glycerol as the
cryoprotectant.
Data Collection and Refinement—The lower resolution data
were collected in-house at 120 K and the higher resolution data
at 100 K at the European Synchrotron Radiation Facility on the
ID23-1 beamline. Statistics are provided in supplemental Table
3. Data were processed and scaled using MOSFLM/SCALA
(39–41). Successful solution of the lower resolution data were
obtained bymolecular replacement usingmodels of 2F1 and 3F1
(PDB code 2RKZ) (25), searched for separately within Phaser
(42). This structurewas refined as described previously (25) and
was used (without PyTT5) as the starting point for refinement
of the higher resolution data using REFMAC (43).
Creation of a Hidden Markov Model—A profile HMM (44)
was assembled using the sequences of known FnBRs (22) and
using structural data (25) to informwhere gaps in the alignment
would be more likely. The HMM was used to search for other
FnBRs in the UniRef90 sequence database (45). A set of nonre-
dundant FnBRs was created from those identified in the search,
in which each FnBR had no more than 70% pairwise identity to
any other FnBR in the set. An HMM representing the nonre-
dundant FnBRs was used in a second search of the database.
This iterative process was repeated three times, until no further
FnBRs were identified. An HMM logo was produced (46) using
a final HMM of all nonidentical FnBRs.
Model of 1–5F1SfbI-5—The model of 1–5F1SfbI-5 was built
from the structure of 2F13F1PyTT5, an alignment between
4F15F1 and S. aureus FnBPA peptide structures (PDB codes
2RKY and 2RL0) (25), and 1F1 and the 1F1-binding region from
the structure of 1F12F1 in complex with B3T (PDB code 1O9A)
(7) using the programMODELLER (47). The 1F12F1 interface is
not well defined even in the presence of peptide (7).
Surface Plasmon Resonance (SPR)—Interactions of SfbI-5
with human Fn and pNTD were studied using SPR. Binding
studies were performed using a BIAcore T100 instrument (GE
Healthcare) at 25 °C. GST-tagged wild-type ormutant (T558A)
SfbI-5 was immobilized onto the experimental flow cell of a
certified C1 sensor chip (GE Healthcare) by amine coupling
usingN-hydroxysuccinimide and ethyl-(dimethylaminopropy-
l)carbodiimide. Ethanolamine was subsequently used to block
the surface. The reference flow cell underwent an identical but
blank immobilization and blocking protocol. The SPR running
buffer was HBSP (10 mM HEPES, pH 7.4, 150 mM NaCl, 0.05%
(v/v) polysorbate 20). Flow rates of 20 and 30 l/min were used
for data acquisition and regeneration, respectively. The analyte
contact and dissociation times were 180 and 600 or 1200 s,
respectively. The longer dissociation time was required for the
interaction of wild-type SfbI-5 with Fn, to ensure dissociation
of a significant amount of analyte from the ligand. Regeneration
contact and stabilization times were 540 and 3000 s, respec-
tively. 0.1 M NaOH was used for regeneration. A kinetic data
series contained sensorgrams measured for seven or eight
sequential 2-fold analyte dilutions from13.9 nM for both Fn and
pNTD. Kinetic data series were fitted to a Langmuir 1:1 binding
model by Biacore T100 evaluation software (GE Healthcare)
using a constant zero bulk refractive index parameter. Anupper
limit for analyte concentration for sensorgram analysis was
determined to ensure reliable curve-fitting indicated by low 2
values. For the interaction between pNTD and SfbI-5 T558A,
steady state affinity analysis was used to determine the binding
affinity by Biacore T100 evaluation software (GE Healthcare)
using a constant zero offset.
RESULTS
SfbI-5 Is an IDR—SfbI-5 binds to pNTD with the highest
affinity (Kd 3 nM at 37 °C) (8) of the FnBRs studied to date.
AlthoughSfbI-5 is predicted to be an IDRbased on its sequence,
this has not been confirmed experimentally. In the absence of
pNTD, the 15N-1H HSQC NMR spectrum of 15N,13C-labeled
SfbI-5 has the narrow linewidths and low chemical shift disper-
sion in the 1Hdimension typical of an IDR (Fig. 1A). To confirm
this observation, standard NMR methods were used to assign
chemical shifts to the 1HN, 15NH, 13C, 13C, and 13C nuclei
(supplemental Table 2). The secondary structure propensity for
each residue was determined by calculation of its SSP score,
using the assigned chemical shifts and those predicted for a
sequence-corrected random coil (Fig. 1B) (37, 38).
No evidence of stable secondary structure or significant SSP
was detected in the 2–5F1-binding region of SfbI-5. This is con-
sistentwith previous circular dichroism results that streptococ-
cal and staphylococcal FnBRs are IDRs (48), and also with a
previous NMR analysis of an FnBR-containing region in S.
aureus FnBPA (6). However, unlike other FnBRs in SfbI, SfbI-5
contains a 1F1-binding region (residues 577–588) (7), and this
region has SSP for -strand conformations (Fig. 1B). In partic-
ular, residues 580–584 have an SSP score of less than 0.3,
indicating thatwithin this regionmore than a third of the SfbI-5
molecules exhibit and angles typical of-strand at any given
time. This provides a plausible explanation for our previous
observation that the 1F12F1-binding motif from SfbI-5 bound
with higher affinity than SfbI peptides that bind 2F13F1 or
4F15F1 (8).
Conservation of FnBR Residues—Fig. 2 shows an HMM logo
(46) assembled from an alignment of all nonredundant staphy-
lococcal, streptococcal, and spirochetal FnBRs identified in the
sequence databases. Fig. 2 shows that, particularly in the FnBR
region that binds 2F13F1, there are residues that are highly con-
served across all FnBRs.
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Effect of Mutation of Conserved FnBR Residues on Affinity of
the Interaction of SfbI-5 with 1–5F1—The effect of mutating
conserved SfbI-5 residues on the binding of SfbI-5 to 1–5F1 was
investigated using ITC. The 2F1- and 4F1-binding regions con-
tain themost conserved FnBR residues (Fig. 2). Additionally, we
have previously shown that, of the 2–5F1-binding regions, only
the 2F1- and 4F1-binding regions show significant binding to F1
module pairs that contain their target F1 module (8). Thus, we
focused the mutation analysis on these regions and on the
highly conserved Gly in the 3F1-binding region. Also, for com-
parison, we mutated two residues with lower levels of conser-
vation, one in the 2F1- and one in the 3F1-binding region.
As can be observed from Table 1 and Fig. 3, when conserved
residues in SfbI-5 were mutated to alanine, the binding became
weaker relative to wild-type SfbI-5. In the one case where a
residue in SfbI-5 that was not the consensus FnBR residue for
that position (Fig. 2) was mutated to the consensus residue
(K556E), the binding was significantly tighter relative to wild-
type SfbI-5. Thus, overall, these results are consistent with the
HMM logo in Fig. 2. However, whereas mutation of all the
conserved residues weakened the interaction, for even themost
conserved FnBR residues, the effect of mutation was relatively
modest when compared with the effect of mutating hot spot
residues on the interactions of folded proteins (defined here as
those that contribute 2 kcal/mol to the interaction (27)).
Key Interactions Are Conserved between S. aureus FnBPAand
S. pyogenes SfbI in Binding to 2F13F1—To test whether residues
conserved across FnBRs play the same functional role in the
binding of different organisms to Fn, we determined the struc-
ture of 2F13F1 in complexwith PyTT5 (the 2F13F1-binding pep-
tide from SfbI-5) and compared it with our previously deter-
mined structures of homologous peptides from S. aureus
FnBPA in complex with 2F13F1 (2F13F1STATT1 and
2F13F1STATT5; PDB codes 2RKZ and 3CAL, respectively
(25)).
Fig. 4 shows the 1.7 Å resolution structure of PyTT5 in com-
plex with 2F13F1 (crystallographic parameters are provided in
supplemental Table 3). It is clear that PyTT5binds the E strands
of 2F1 and 3F1 through a tandem-zippermechanism (Fig. 4,A
and B), with PyTT5 residues 562–565 and 570–574 adopting 
and  angles typical of the -strand. As expected, there is little
difference in the F1 module structures; comparison of the
structure with that of 2F13F1STATT1 shows a root mean
square deviation of 2.11 Å between 2F13F1 in the two
structures.
The side chains of the PyTT5 3F1-binding region (residues
560–565) interact with 3F1 primarily via van der Waals contacts,
with Met-562 contacting Leu-134 and Arg-125 in 3F1, and Phe-
565 stacking against aliphatic side-chain atoms of Lys-143 and
Glu-145 (Fig. 4C). Furthermore, a glycine at position 564 allows
PyTT5 to adopt a -strand conformation without a steric clash
with Trp-146 in 3F1 (Fig. 4C). Thus, the highly conserved glycine
identified in Fig. 2 performs the same function in this structure as
in the two structures of 2F13F1 with S. aureus peptides (25).
The PyTT5 linker region (residues 566–569) does not
loop away from 2F13F1 as in the 2F13F1STATT1 and
2F13F1STATT5 structures (25), although it is the same length
as the linker region in STATT5 (25). Instead, the PyTT5 linker
binds to the interface between 2F1 and 3F1 primarily via hydro-
gen bonds; the side chains of bacterial residues Ser-566 and
Glu-567 participate in hydrogen bond networks involving res-
idues in both 2F1 and 3F1 (Fig. 4C).
The PyTT5 2F1-binding region (residues 570–577) binds to
2F1 via both van der Waals and hydrogen bond interactions.
The two key van derWaals contacts are between the side chains
of the bacterial residues Ile-571 and Asp-574 and the side
chains of Trp-90 and Arg-99 of 2F1, respectively. Thr-570
forms a hydrogen bond with the side chain of Thr-105 in 2F1,
adopting a staggered conformation favored in -sheets (49).
The side chain of Glu-573 exists in two conformations in both
FIGURE 1. SfbI-5 is intrinsically disordered. A, 1H,15N HSQC spectrum of
15N,13C-labeled SfbI-5. The peaks in the spectra were assigned to the 1HN and
15NH resonances of SfbI-5 residues using standard procedures. Each peak is
labeled according to its position in the full-length SfbI-5 sequence. The peak
annotated I(540) is not native to full-length SfbI but is directly N-terminal to
Pro-541 from native SfbI, and the peak annotated R576 is from the side chain
of Arg-576. The other smaller unassigned peaks in close proximity to assigned
resonances are likely to arise from residues near a proline as a result of the
proline being in a cis-conformation. Inset is an enlarged area of the boxed
region of the spectrum. B, sequence-corrected SSP score was calculated for
SfbI-5 using all available chemical shift information. SSP scores of 1 and 1
represent a stable -helix and -strand, respectively. A score of 0 represents
random coil.
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2F13F1PyTT5 complexes in the asymmetric unit with 50%
occupancy in each conformation. One of the conformations
results in a salt bridge to the side chain ofArg-83 in 2F1 (Fig. 4D)
as found for the corresponding side chain in both complexes of
S. aureus peptides with 2F13F1 (25). The second Glu-573 side-
chain conformation forms a hydrogen bond to the carbonyl
group of Asp-574 via a bridging water molecule (Fig. 4D). The
side chain ofAsp-574 forms a salt bridgewith bothArg-101 and
Arg-99, and Thr-575 forms hydrogen bonds to the backbone
atoms of Gly-100 and Phe-67, although the latter is via a bridg-
ing water molecule (Fig. 4D). Therefore, the PyTT5 residues
corresponding to the conserved “E(D/E)(T/S)” motif identified
in Fig. 2 form interactions in the complex that are very similar
to those of the corresponding residues in the 2F13F1STATT1
and 2F13F1STATT5 complexes (25).
PyTT5 Efficiently Forms an Extended Interface with 2F13F1—
The extent of the interface between PyTT5 and 2F13F1 was
analyzed using ProFace (50). A protein interface can be divided
into two categories at both the atom and residue level (51, 52).
At the atom level, the interface can be divided into buried and
accessible interface atoms, where buried atoms lose all accessi-
ble surface area (ASA) on complex formation, and accessible
atoms lose some ASA. The ProFace analysis showed that every
residue of PyTT5 is involved in the interface with 2F13F1, with
at least one atom of each residue in PyTT5 having some buried
surface area at the interface (Fig. 5A; Table 2).
At the residue level, the interface can be divided into core and
rim residues, with core residues containing at least one buried
interface atom and rim residues containing at least one acces-
sible interface atom and no buried interface atoms. By this def-
inition, 14 of the 18 residues (78%) in PyTT5were core residues,
and the remaining residues were rim residues (32%). In com-
parison, 2F13F1 had 20 core residues (22%) and 18 rim residues
(20%) out of a total of 89 residues (Table 2). This indicates that
FIGURE 2. Conserved FnBR residues identified with an iterative HMM search of the UniRef90 database. A, shown above the HMM logo are the crystal
structures of 2F13F1 and 4F15F1 (purple) bound to FnBPA-1 peptides (gray) shown in ribbon representation (25). Conserved FnBPA-1 and F1 module side chains
important in the interaction are shown in stick representation and are colored yellow or cyan, respectively. Hydrogen bonds are shown as black dashed lines and
two bridging water molecules as gray spheres. B, sequences of FnBPA-1 (residues 476 –514) and the SfbI-5 2–5F1-binding region (residues 544 –578) are aligned
to the columns in the HMM logo. Conserved FnBPA-1 side chains are also highlighted yellow in the FnBPA-1 sequence, and SfbI-5 residues chosen for mutation
to alanine are highlighted green. The SfbI-5 residue Lys-556 is underlined; this residue was also mutated separately to glutamate. Regions of FnBPA-1 that form
a -strand when bound to F1 modules are indicated above the sequences by gray arrows. The logo was drawn with the LogoMat-M server (46).
TABLE 1
Thermodynamic parameters for the interaction between pNTD and SfbI-5 (wild-type and mutants) determined by ITC at 37 °C, pH 7.4
SfbI-5 or SfbI-5 mutant Kd H0 S0 G0 G0
nM kcal/mol cal mol1 K1 kcal/mol kcal/mol
SfbI-5 3.5  0.2 45.4  0.7 108 11.99  0.04 0.00  0.06
V552A 10.6  0.8 44.3  0.2 106 11.30  0.05 0.69  0.06
E553A 8.4  0.8 45.2  0.3 109 11.45  0.06 0.54  0.08
F554A 31.5  4.9 42.9  0.7 104 10.63  0.10 1.36  0.10
K556A 1.6  0.2 45.7  1.4 107 12.46  0.08 0.47  0.09
K556E 0.8  0.2 49.0  2.4 116 12.90  0.18 0.90  0.18
D557A 13.8  1.0 43.2  0.2 103 11.14  0.05 0.85  0.06
T558A 55.4  2.7 37.9  1.6 89.0 10.29  0.03 1.70  0.05
M562A 8.2  0.4 40.0  0.1 92.2 11.46  0.03 0.53  0.05
G564A 28.7  2.1 38.5  0.2 89.6 10.69  0.04 1.30  0.06
I571A 7.7  0.3 44.5  0.1 106 11.50  0.03 0.49  0.05
E573A 13.9  0.8 43.6  0.2 105 11.14  0.03 0.85  0.06
D574A 41.0  5.9 46.3  1.2 116 10.47  0.09 1.52  0.10
T575A 11.1  0.5 44.9  0.4 108 11.27  0.03 0.72  0.05
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each residue of PyTT5 contacts, on average, more residues of
2F13F1 than vice versa. It also indicates that a much greater
percentage of PyTT5 is involved in the interface comparedwith
2F13F1. This is further shown by the fact that 40% of the ASA of
PyTT5 is buried at the interface, comparedwith 17%of theASA
of 2F13F1. Thus, PyTT5 is a very efficient ligand. These proper-
ties have been noted in other complexes involving IDRs (32, 53,
54).
SfbI-5 Is Predicted to Form a Large, Extended Interface with
1–5F1—Structural data are now available for a single
1F12F1FnBR peptide complex (7), three 2F13F1FnBR (25) pep-
tide complexes, and two 4F15F1FnBR peptide complexes (25),
so it is intriguing to consider the extent of the interface between
SfbI-5 and 1–5F1. ProFace analysis of a model of 1–5F1 bound to
SfbI-5 (Fig. 6) predicts that the total buried surface area of the
interface would be 5150 Å2. This is a very large interface for a
heterocomplex. In fact, comparison between the predicted
interface area of 1–5F1SfbI-5 and the observed interface areas
from a set of heterodimer complex structures from the Protein
Data Bank (32) reveals that the predicted interface is larger than
any of the interfaces in the dataset andmore than 1500Å2 larger
than the largest complex involving an IDR.
Furthermore, 40% of the ASA of SfbI-5 is buried in the inter-
face, comparedwith 18% of theASA of 1–5F1. Thus, the reasons
PyTT5 is an efficient ligand for binding to 2F13F1 are also pre-
dicted to make SfbI-5 an efficient ligand when in complex with
1–5F1. For a globular protein to bury a similar amount of surface
area, it would have to have two to three times more residues.
Therefore, a probable biological advantage of the intrinsic dis-
order of SfbI-5 is large interface formation (and tight binding)
with fewer resources committed on the part of S. pyogenes (53).
Effect of Mutation of Conserved FnBR Residues on Affinity of
the Interaction of SfbI-5 with Fn—In vivo, SfbI-5 interacts with
1–5F1 in the context of intact Fn. Thus, the effect of the muta-
tion of conserved FnBR residues on binding to plasma Fn was
also determined (Fig. 7). SPR was first used to determine the
dissociation constants for binding to pNTD (to compare with val-
ues obtained using ITC). Using the Van’t Hoff isochore to adjust
for the temperature difference, we estimate that the ITC experi-
ments would yield an affinity of 0.18 nM if performed at 25 °C
comparedwith the SPR-measured value of 0.14 nM. The effects of
mutation were also similar, with the T558A mutation causing a
19-fold reduction in the affinity whenmeasured using SPR (Table
3) compared with a 16-fold reduction in affinity when measured
FIGURE 3. ITC studies of SfbI-5 (wild-type and mutants) binding to pNTD. A, wild-type; B, K556E; C, K556A; D, M562A; E, E553A; and F, T558A. In each
sub-figure, the top panel shows the experimental trace as a solution of SfbI-5 (or SfbI-5 mutant) was titrated into a pNTD solution. When a control titration was
used to account for heats of dilution it is also shown but is displaced by 0.03 cal/s. The bottom panel shows the processed molar heats of binding normalized
to the ratio between SfbI-5 (or SfbI-5 mutant) to pNTD. For each titration, the curve from nonlinear least squares regression analysis, using a single-site binding
model, is shown in gray. Thermodynamic parameters derived from these experiments are in Table 1.
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using ITC (Table 1). When binding of Fn to wild-type SfbI-5 and
the T558A mutant was compared, the mutation resulted in an
5-fold reduction in the affinity. Thus, the T558A mutation has
an even smaller effect on binding to Fn.
DISCUSSION
SfbI-5 Is an IDR—Comparison of the chemical shifts of the
SfbI-5 1HN, 15NH, 13C, 13C, and 13C nuclei with sequence-
corrected random coil values revealed that SfbI-5 is an IDR,
with no evidence of any stable secondary structure. However,
the C-terminal 1F1-binding region of SfbI-5 showed significant
propensity for -strand formation (Fig. 1B). Based on a
sequence alignment between SfbI-5 and the Streptococcus dys-
galactiaeFnBRpeptideB3T,whose structure has been solved in
complex with 1F12F1 (7), the residues with high -strand pro-
pensity are predicted to form a -strand when bound to 1F1.
Therefore, this regionmight be a preformed structural element
primed for 1F1 recognition (55).
Conserved Residues in Streptococcal and Staphylococcal
FnBRs Perform Similar Functions—The crystal structure of
PyTT5 in complex with 2F13F1 shows that the peptide binds to
FIGURE 4. Structure of 2F13F1PyTT5. PyTT5 (green) binds along the E strands of both modules in 2F13F1 (purple). A, one of the two 2F13F1PyTT5 complexes
in the asymmetric unit. B, 2F13F1PyTT5 structure showing the difference density at a level of 1 (gray) when the PyTT5 molecule is deleted. C, interaction
between 2F13F1 and the 3F1-binding and linker regions of PyTT5 shown as a stick representation. D, interaction between 2F1 and the 2F1-binding region of
PyTT5 shown as a stick representation. In both C and D, hydrogen bonds and salt bridges are black dashes, and invariant bridging water molecules are shown
as gray spheres. Residues mentioned in the text are labeled.
FIGURE 5. Interface between 2F13F1 and PyTT5. Surface representation of
2F13F1 and PyTT5 (left and right, respectively) showing the interface between
2F13F1 and PyTT5. Indicated are the 2F1 and 3F1 modules, as are the regions of
PyTT5 that bind 2F1 and 3F1. The schematic above the interfaces shows how
the complex was opened like a book to reveal the interface. A, interface is
shown at the atom level and is represented as buried and accessible atoms,
which are colored red and blue, respectively. B, interface is shown at the resi-
due level and is represented as core (magenta) and rim (cyan) residues. Resi-
due and atom accessibility was calculated from the output of ProFace (50).
FIGURE 6. Model of the 1–5F1-SfbI-5 complex. Ribbon representation of a
model of SfbI-5 (green) in complex with 1–5F1 (purple).
TABLE 2
Analysis of the interfaces in the 2F13F1-PyTT5 complex by change in
ASA on complex formation
Statistics for the interface between 2F13F1 chain B and PyTT5 chain D were calcu-
lated with the ProFace server (50). Local density is a measure of the atomic packing
at the interface (64).
Complex
2F13F1-PyTT5 (molecule, chain)
2F13F1, B PyTT5, D Complex
Interface area
Total 851.4 Å2 1095.6 Å2 1947.0 Å2
Core 653.1 Å2 853.0 Å2 1506.1 Å2
Rim 241.5 Å2 242.6 Å2 484.1 Å2
Interface area/surface area 0.17 0.41 0.24
No. of interface atoms
Total 122 89 211
Buried 44 22 66
Accessible 78 67 145
No. of interface residues
Total 38 18 56
Core 20 14 34
Rim 18 4 22
Fraction of nonpolar atoms 0.57 0.60 0.58
Nonpolar interface area 443.5 Å2 592.3 Å2 1035.8 Å2
Fraction of fully buried atoms 0.36 0.25 0.31
Local density 36.56 32.70
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2F13F1 via a tandem -zipper (Fig. 4A). Comparison of this
structurewith those of FnBPApeptides in complexwith 2F13F1
(25) revealed that residues that were conserved between these
peptides formed similar interactions with 2F13F1. Given the
sequence similarity between the other F1-binding regions of
SfbI with FnBR peptides that have been solved in complex with
4F15F1 and 1F12F1 (7, 25), it is highly likely that SfbI-5 will bind
to 1F1 and 4F15F1 via a tandem -zipper. Thus, we prepared a
model of the intact complex that highlights the extraordinary
efficiency of the interaction (Fig. 6).
High efficiency of extended interface formation has been
proposed as a potential advantage of intrinsic disorder (53),
and overall, the interface area per IDR residue is higher in pro-
tein-protein heterocomplexes containing an IDR than for com-
plexes containing two folded proteins (32). The tandem
-zipper interaction of SfbI-5 with 1–5F1 provides a clear dem-
onstration of the efficiency of extended interface formation and
the high affinity that can be achieved by an IDR. As seen previ-
ously for FnBR peptide interactions with F1 modules, there is
little change in the 2F13F1 structure on PyTT5 binding.
Analysis of G0 Values—The effect of mutating conserved
SfbI-5 residues on the binding of SfbI-5 to pNTD was deter-
mined by calculating the G0 for binding of the SfbI-5
mutants relative to wild-type SfbI-5 (Table 1). Most of the
effects of the mutations can be rationalized from the structures
based on the loss of buried atoms or intermolecular hydrogen
bonds involving the mutated residue.
Some of the effects of mutations could also have been pre-
dicted based on residue conservation (Fig. 2). For example,
K556A had a small but favorable G0 of 0.47 kcal/mol and
K556E had a more favorable G0 of 0.90 kcal/mol. This
result would be predicted from Fig. 2 as glutamate is the most
conserved residue at this position. Also, for G564A, the unfa-
vorable change in free energy is likely caused by changes in
surrounding interactions that are required to avoid a steric
clash between the alanine side chain and Trp-146 of 3F1
(Fig. 4C).
However, a comparison of Table 1 and Fig. 2 shows that over-
all there is not a strong correlation between the level of conser-
vation of a residue and the G0 value for mutation of that
residue. The largest effect is observed for T558A, yet Thr-558 is
not, by some way, the most highly conserved residue. Ile-571
andMet-562weremutated because they are lesswell conserved
(Fig. 2) and were predicted to form -strand interactions with
an F1 module primarily via backbone-backbone hydrogen
bonds, a prediction that was confirmed by the 2F13F1PyTT5
structure (Fig. 4,C andD). Yet the small G0 values (0.49 and
0.53 kcal/mol, respectively) for mutation of these residues are
similar to that observed for the mutation of a highly conserved
acidic residue (Glu-553) in the conserved E(D/E)(T/S) motif
within the 2F1-binding region.
Energy of the NTD/SfbI-5 Interaction Is Distributed across the
Interface—All mutations of conserved residues reduced the
affinity of binding, but G0 values were relatively small (	2.0
kcal/mol) compared with similar analyses on mutating inter-
faces in globular complexes (56, 57). Some analyses use a differ-
ent threshold (e.g.G0 1 kcal/mol (31)) for defining hot spot
residues. The latter threshold would mean that four SfbI-5 res-
idues were hot spots (Phe-554, Thr-558, Gly-564, and Asp-
574). Interestingly, only one of these residues is from the 2F1-
binding region, yet it is this region that binds more tightly to
2F13F1 (8). However, regardless of the threshold chosen, it is
clear fromTable 1 that in theNTD/SfbI-5 interaction, the bind-
ing energy is distributed across the large interface rather than
being concentrated in a few residues.
It has been observed that hot spots tend to be core residues,
and tend not to be rim residues. This is because core residues
form side-chain interactions with the protein partner, and rim
residues act like an “o-ring” and shield the core residues from
water (58). However, the extended nature of PyTT5, when in
complex with 2F13F1, means that PyTT5 does not contain an
o-ring of rim residues (Fig. 5B). Based on our model (Fig. 6),
intact SfbI-5, when in complex with 1–5F1, would also lack
o-ring residues. The reason thismight lead to the absence of hot
spots can be better understood by considering the interface at
the level of atoms.
FIGURE 7. SPR studies of GST-SfbI-5 (wild-type and T558A) binding to Fn.
Either GST-SfbI-5 (A) or SfbI-5 T558A (B) was immobilized on the chip. Dimeric
plasma Fn was used as the analyte. SPR response curves, base-line corrected,
are shown in black; and the best fits to the data of Langmuir 1:1 models are
shown in gray. Parameters derived from these experiments are shown in
Table 3.
TABLE 3
Parameters for the interaction of pNTD and Fn with SfbI-5 and the T558A mutant determined using SPR at 25 °C, pH 7.4
Construct k1a k1a Kd G0 G0
 107 M1 s1  104 s1 nM kcal/mol kcal/mol
pNTD
SfbI-5 2.89 39.7 0.137  0.002 13.44  .01 0.00
T558A NDb NDb 2.6  0.3 11.71  .07 1.74  0.07
Fn
SfbI-5 0.462 1.405 0.030  0.001 14.35  .00 0.00
T558A 0.170 2.33 0.137  0.004 13.44  .02 0.91  0.02
a For each experiment, the errors for k1, k1, and Kd were calculated from the errors in fitting the data from a single kinetic series to a Langmuir 1:1 binding model. The fit-
ting model minimizes the errors associated with each variable. For all experiments, the errors for k1 and k1 came out to zero when expressed to a suitable number of sig-
nificant figures.
b NDmeans not determined. The data obtained for T558ApNTD did not fit a kinetic model and was therefore fitted to a steady state affinity model. Thus, there are no ki-
netic data available for this experiment.
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At the atom level of protein/protein interactions, the main
chain is not directly affected by site-directed mutagenesis to
alanine (51). Also, when accessible interface atoms are removed
bymutation, they can be replaced bywatermolecules at a lower
energetic cost than buried atoms (51). By this rationale, hot spot
residues are likely to contain a buried interface atom that is
deleted when the residue is mutated to alanine. Only 2 of 22
(9.1%) buried interface atoms in PyTT5 but 14 of 44 (32%) in
2F13F1 fulfill these criteria. Therefore, it appears the extended
nature of the interface between SfbI-5 and 1–5F1, which is facil-
itated by the intrinsic disorder of free SfbI-5, is likely to pre-
clude the presence of hot spot residues in SfbI-5. A more even
distribution of the free energy of binding might be a more gen-
eral property of complexes containing IDRs that have extended
interfaces (32) that are unlikely to shield important interacting
residues from water.
Weused theHotPOINT server (29, 59) to predict hot spots in
2F13F1PyTT5 and S. aureus FnBR peptides in complex with
2F13F1 (2RKZ and 3CAL) and 4F15F1 (2RKY and 2RL0) (25).
Consistent with our ITC results, this analysis also suggests an
overall lack of hot spots in the FnBR peptides with only a single
conserved residue in the FnBR peptides (and only in 2RL0) pre-
dicted to be a hot spot.
A Paradox and a Challenge—We have shown that conserved
residues in FnBRs of S. pyogenes and S. aureus play equivalent
functional roles in binding to Fn and that single interactions can
be sacrificed (in vitro) while maintaining a high affinity interac-
tion. But why then are the FnBR residues so conserved? Are the
conserved residues important for an aspect not probed by our
pNTD interaction assay or are the small changes in affinity
observed functionally significant?
Other potential functional roles for the conserved residues
that are not probed by the pNTD binding assay are the disrup-
tion of intramolecular Fn interactions and/or maintenance of
disorder in the FnBR. Long range intramolecular interactions
between 2–5F1 and Fn type 3 modules (60) have recently been
shown to mask motogenic sites within the collagen-binding
domain of Fn. Changes in chemical shifts in the N-terminal
strand (A strand) and E strands of F1 modules on F3 module
binding (60) suggests that the F3- and SfbI-5-binding sites on
2–5F1 partially overlap. The faster association rate observed for
binding of wild-type SfbI-5 to pNTD compared with Fn (Table
3) is consistent with the FnBR-binding site being somewhat
cryptic in Fn. Therefore, we reasoned that conserved residues
might play a role in unmasking the binding site, and thus, the
effect of their mutation would only be observed when binding
to Fn (rather than pNTD) was measured. However, the muta-
tion that had the largest effect on SfbI-5 binding to pNTD
(T558A) had an even smaller effect on the Kd for binding to
intact Fn, suggesting that the interaction with Fn also lacks hot
spots in the IDR.
Conserved residues might also play a role in maintaining the
disordered state of FnBRs, similar to conservation of structur-
ally important residues in a folded protein. By definition, disor-
dered proteins do not make enough energetically favorable
intramolecular contacts to overcome the unfavorable entropy
of folding to fold into a stable tertiary structure. This is achieved
by a characteristic amino acid composition, with IDRs having
on average more charged and polar residues and fewer hydro-
phobic residues (61). It also requires each residue to limit the
number of favorable interactions it makes with its neighboring
residues (62). Therefore, there might be selective pressure for a
disorder-promoting residue at a given position in an IDR
depending on its neighboring sequence. Whether this selective
pressure exists in FnBRs is hard to identify given current knowl-
edge of IDR residue conservation.
Only streptococcal FnBPs and, in each case, only the C-ter-
minal FnBR in the protein contain a 1F1-binding motif. These
1–5F1-binding FnBRs bindNTDwith higher affinity than 2–5F1-
binding FnBRs in SfbI (8). For example, in our previous study
SfbI-5 bound pNTDwith aKd of2 nM at 37 °C, whereas SfbI-4
boundwith aKd of 60 nM at 25 °C (8). Although S. aureus FnBPs
only contain 2–5F1-binding FnBRs, the C-terminal FnBR
(FnBPA-11) also binds NTDwith the highest affinity, i.e. Kd 	1
nM at 25 °C compared with 5 nM for FnBPA-1 (10). Thus, selec-
tive pressure for themaintenance of high affinity binding at the
most C-terminal FnBR might operate in vivo, for example, at
the level of integrin-mediated bacterial invasion.
The extended, multidomain nature of the tandem -zipper
interface is a plausible (and intuitive) explanation for the appar-
ent absence of hot spots in SfbI-5. The mutation analysis of the
NTD/SfbI-5 interaction presented here provides experimental
support for this intuition. This interaction is, as yet, unusual
with the only other reported example in LIM/Ldb interactions
(54). However, extended interactions appear to be favored by
IDRs (32), and thus, we suggest that IDRs in general might be
more likely to form interactions that lackwell defined hot spots.
Rational design strategies for drugs that target protein/pro-
tein interactions are still in the relatively early stages of devel-
opment (28). The additional challenges involved in the design
of drugs that target interactions involving IDRs have recently
been highlighted (63). The more even distribution of binding
energy over the interface, as observed here, than is commonly
observed in the binding of folded proteins will add a further
challenge, specifically for development of inhibitors of FnBP-
mediated invasion of host cells and perhaps more generally for
interactions involving IDRs.
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